Skip to main content
Premium Trial:

Request an Annual Quote

Backed by $15M in VC, New Company Will Help ISB Startups

NEW YORK, May 23 - The Institute of Systems Biology, three venture capital firms, and a real estate firm have formed a company called Accelerator that will help startups emerging from, or affiliated with, the ISB get off the ground.


MPM Capital, Arch Venture Partners, Versant Ventures, and Alexandria Real Estate Equities together committed $15 million in capital in a financing led by MPM.


Accelerator plans to identify, finance, and develop ideas and technologies emerging from the ISB or other places affiliated with it. It will provide management, infrastructure, and facilities for startup companies and help them raise further funding.


Leroy Hood, the ISB's president, is a member of the board of directors of Accelerator.



The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.